Invest now
Concord Drugs Key Metrics
BSE: 538965 | NSE: - | ISIN: INE858L01010 | Sector: Biotechnology & Drugs70.40 -0.60 (-0.85%)Updated : 09 Oct 2026
Research on
Ratios
| Return on average equity - 5 year average | 2.68 |
| Net Income/employee - trailing 12 month | 0.00 |
| Revenue/employee - most recent fiscal year | 0.00 |
| Return on investment - most recent fiscal year | 2.27 |
| Return on average assets - most recent fiscal year | 1.51 |
| Receivables turnover - most recent fiscal year | 4.15 |
| Return on investment - trailing 12 month | 0.00 |
| Return on average assets - trailing 12 month | 0.00 |
| Inventory turnover - most recent fiscal year | 2.66 |
| Inventory turnover - trailing 12 month | 0.00 |
| Revenue/employee - trailing 12 month | 0.00 |
| Return on average assets - 5 year average | 1.48 |
| Net Income/employee - most recent fiscal year | 0.00 |
| Return on average equity - trailing 12 month | 0.00 |
| Receivables turnover - trailing 12 month | 0.00 |
| Asset turnover - most recent fiscal year | 1.12 |
| Asset turnover - trailing 12 month | 0.00 |
| Return on average equity - most recent fiscal year | 2.55 |
| Return on investment - 5 year average | 2.33 |
Concord Drugs Quick Links
Concord Drugs Dividend Concord Drugs Bonus Concord Drugs News Concord Drugs AGM Concord Drugs Rights Concord Drugs Splits Concord Drugs Board Meetings Concord Drugs Shareholdings Concord Drugs Profit Loss Concord Drugs Balance Sheet Concord Drugs Cashflow Concord Drugs Q1 Results Concord Drugs Q2 Results Concord Drugs Q3 Results Concord Drugs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,035.00+40.00(4.02%)
2,079.30+29.30(1.43%)
1,246.00+17.00(1.38%)
11,400.00-549.00 (-4.59%)
2,851.05-96.35 (-3.27%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.